Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

NCT01107743 · clinicaltrials.gov ↗

COMPLETED

Status

1291

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Angina Pectoris
Hypercholesterolemia
Familial Hypercholesterolemia

Interventions

DRUG: Amlodipine/Atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.